Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives

키워드

참고문헌 (99)

1. Fu Wang, "Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells", BMB reports, 42(11), pp.725~730 (2009), 한국생화학분자생물학회
2. Hausser J, "Identification and consequences of miRNA-target interactions--beyond repression of gene expression", Nat Rev Genet, 15, pp.599~612 (2014)
3. Wu BL, "MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145", World J Gastroenterol, 17, pp.79~88 (2011)
4. Tokarz P, "The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment", Acta Biochim Pol, 59, pp.467~474 (2012)
5. Lee Y, "The nuclear RNase III Drosha initiates microRNA processing", Nature, 425, pp.415~419 (2003)
6. Yi R, "Exportin-5mediates the nuclear export of pre-microRNAs and short hairpin RNAs", Genes Dev, 17, pp.3011~3016 (2003)
7. Finnegan EF, "MicroRNA biogenesis: regulating the regulators", Crit Rev Biochem Mol Biol, 48, pp.51~68 (2013)
8. Hamfjord J, "Differential expression of miRNAs in colorectal cancer:comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing", PLoS One, 7, pp.e34150~ (2012)
9. Lu J, "MicroRNA expression profiles classify human cancers", Nature, 435, pp.834~838 (2005)
10. Weber JA, "The microRNA spectrum in 12 body fluids", Clin Chem, 56, pp.1733~1741 (2010)
11. Chen X, "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases", Cell Res, 18, pp.997~1006 (2008)
12. Arends MJ, "Pathways of colorectal carcinogenesis", Appl Immunohistochem Mol Morphol, 21, pp.97~102 (2013)
13. Siegel RL, "Cancer statistics, 2016", CA Cancer J Clin, 66, pp.7~30 (2016)
14. Tarasov VA, "Coordinated aberranit expression of miRNAs in colon cancer", Genetika, 50, pp.1232~1244 (2014)
15. Fesler A, "Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer", Epigenomics, 9, pp.793~796 (2017)
16. Stiegelbauer V, "MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer", World J Gastroenterol, 20, pp.11727~11735 (2014)
17. Schee K, "Deep sequencing the microRNA transcriptome in colorectal cancer", PLoS One, 8, pp.e66165~ (2013)
18. Thiery JP, "Epithelial-mesenchymal transitions in development and disease", Cell, 139, pp.871~890 (2009)
19. Shi L, "p53-induced miR-15a", 16-1 and AP4form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer, 2014, pp.74, 532~542
20. Liu R, "MicroRNAs 15A and 16-1activate signaling pathways that mediate chemotaxis of immune regulatory B cells to colorectal tumors", Gastroenterology, 154, pp.637~651 (2018)
21. Dai L, "Vector-based miR-15a", 16-1 plasmid inhibits colon cancer growth in vivo, 2012, pp.36, 765~770
22. Cheng HH, "Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan", Proc Natl Acad Sci U S A, 109, pp.13231~13236 (2012)
23. Young LE, "The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2", Mol Cancer Res, 10, pp.167~180 (2012)
24. Chivukula RR, "An essential mesenchymal function for miR-143", 145 in intestinal epithelial regeneration, 2014, pp.157, 1104~1116
25. Akao Y, "MicroRNAs 143and 145 are possible common onco-microRNAs in human cancers", Oncol Rep, 16, pp.845~850 (2006)
26. Takagi T, "Decreased expression of microRNA-143and -145 in human gastric cancers", Oncology, 77, pp.12~21 (2009)
27. Szczyrba J, "The microRNA profile of prostate carcinoma obtained by deep sequencing", Mol Cancer Res, 8, pp.529~538 (2010)
28. Wang W, "Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1", Oncotarget, 7, pp.68674~68687 (2016)
29. Drebber U, "Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy", Int J Oncol, 39, pp.409~415 (2011)
30. Li C, "Inhibition of SW620 human colon cancer cells by upregulating miRNA-145", World J Gastroenterol, 22, pp.2771~2778 (2016)
31. Xu XH, "Identification of miRNAs differentially expressed in clinical stages of human colorectal carcinoma-an investigation in Guangzhou, China", PLoS One, 9, pp.e94060~ (2014)
32. Pramanik D, "Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice", Mol Cancer Ther, 10, pp.1470~1480 (2011)
33. Ibrahim AF, "MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma", Cancer Res, 71, pp.5214~5224 (2011)
34. Tanoglu A, "MicroRNA expression profile in patients with stage II colorectal cancer: A turkish referral center study", Asian Pac J Cancer Prev, 16, pp.1851~1855 (2015)
35. Roy P, "Engineered andrographolide nanosystems for smart recovery in hepatotoxic conditions", Int J Nanomedicine, 9, pp.4723~4735 (2014)
36. Kang SM, "MicroRNA-365regulates NKX2-1, a key mediator of lung cancer", Cancer Lett, 335, pp.487~494 (2013)
37. Zhang P, "MicroRNA-365inhibits vascular smooth muscle cell proliferation through targeting cyclin D1", Int J Med Sci, 11, pp.765~770 (2014)
38. Guo SL, "Akt-p53-miR-365-cyclin D1", cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency, 2013, pp.4, 2544~
39. Lea MA, "Recently identified and potential targets for colon cancer treatment", Future Oncol, 6, pp.993~1002 (2010)
40. Nie J, "microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2", Carcinogenesis, 33, pp.220~225 (2012)
41. Zhou X, "Identifying miRNA", mRNA negative regulation pairs in colorectal cancer, 2015, pp.5, 12995~
42. Papetti M, "Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365", Am J Physiol Gastrointest Liver Physiol, 301, pp.G508~G518 (2011)
43. Hermeking H, "The miR-34 family in cancer and apoptosis", Cell Death Differ, 17, pp.193~199 (2010)
44. Chang TC, "Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis", Mol Cell, 26, pp.745~752 (2007)
45. He L, "A microRNA component of the p53 tumour suppressor network", Nature, 447, pp.1130~1134 (2007)
46. Jamieson NB, "MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma", Clin Cancer Res, 18, pp.534~545 (2012)
47. Gao J, "miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II", III colorectal cancer, 2015, pp.34, 4142~4152
48. Hiyoshi Y, "Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer", PLoS One, 10, pp.e0124899~ (2015)
49. Ge P, "Aberrant methylation of the 1p36 tumor suppressor gene RIZ1 in renal cell carcinoma", Asian Pac J Cancer Prev, 16, pp.4071~4075 (2015)
50. Roy S, "Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF", J Hematol Oncol, 5, pp.58~ (2012)
51. Svoboda M, "Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer", Int J Oncol, 33, pp.541~547 (2008)
52. Wang J, "The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation", Nat Genet, 41, pp.125~129 (2009)
53. Balaguer F, "Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis", Cancer Res, 70, pp.6609~6618 (2010)
54. Chen J, "Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells", Oncotarget, 8, pp.19609~19630 (2017)
55. Schaller MD, "Paxillin: a focal adhesion-associated adaptor protein", Oncogene, 20, pp.6459~6472 (2001)
56. Liang L, "MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2", Gastroenterology, 144, pp.624~635 (2013)
57. Ng EK, "MicroRNA-143targets DNA methyltransferases 3A in colorectal cancer", Br J Cancer, 101, pp.699~706 (2009)
58. Chen X, "Role of miR-143targeting KRAS in colorectal tumorigenesis", Oncogene, 28, pp.1385~1392 (2009)
59. Pichler M, "Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer", Br J Cancer, 106, pp.1826~1832 (2012)
60. Borralho PM, "MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116human colorectal cancer cells", FEBS J, 276, pp.6689~6700 (2009)
61. Qian X, "MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers", Cell Cycle, 12, pp.1385~1394 (2013)
62. Liu GH, "Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer", Tumour Biol, 34, pp.2175~2181 (2013)
63. Kanaan Z, "Plasma miR-21: a potential diagnostic marker of colorectal cancer", Ann Surg, 256, pp.544~551 (2012)
64. Aherne ST, "Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression", BMC Cancer, 15, pp.329~ (2015)
65. Imaoka H, "Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer", Ann Oncol, 27, pp.1879~1886 (2016)
66. Kanaan Z, "A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer", Ann Surg, 258, pp.400~408 (2013)
67. Ahmed FE, "miRNA as markers for the diagnostic screening of colon cancer", Expert Rev Anticancer Ther, 14, pp.463~485 (2014)
68. Yi R, "MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer", World J Gastrointest Oncol, 8, pp.330~340 (2016)
69. Ebert MS, "MicroRNA sponges:progress and possibilities", RNA, 16, pp.2043~2050 (2010)
70. Jung J, "Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge", Oncotarget, 6, pp.20370~20387 (2015)
71. Shen B, "Long non-coding RNA FBXL19-AS1 plays oncogenic role in colorectal cancer by sponging miR-203", Biochem Biophys Res Commun, 488, pp.67~73 (2017)
72. Xu J, "The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer", Cell Physiol Biochem, 41, pp.635~644 (2017)
73. Wu X, "Long non-coding RNA ucoo2kmd.1 regulates CD44-dependent cell growth by competing for miR-211-3p in colorectal cancer", PLoS One, 11, pp.e0151287~ (2016)
74. Gumireddy K, "Small-molecule inhibitors of microrna miR-21 function", Angew Chem Int Ed Engl, 47, pp.7482~7484 (2008)
75. Valeri N, "MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer", Cancer Cell, 25, pp.469~483 (2014)
76. Chai H, "miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines", Acta Biochim Biophys Sin (Shanghai), 43, pp.217~225 (2011)
77. Valeri N, "MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)", Proc Natl Acad Sci U S A, 107, pp.21098~21103 (2010)
78. Huang Z, "MicroRNA-95promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma", Cancer Res, 71, pp.2582~2589 (2011)
79. Tsang WP, "Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer", Carcinogenesis, 31, pp.350~358 (2010)
80. Wang CJ, "Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells", BMC Cancer, 10, pp.616~ (2010)
81. van Rooij E, "Development of microRNA therapeutics is coming of age", EMBO Mol Med, 6, pp.851~864 (2014)
82. Christopher AF, "MicroRNA therapeutics: Discovering novel targets and developing specific therapy", Perspect Clin Res, 7, pp.68~74 (2016)
83. Kawai T, "The role of patternrecognition receptors in innate immunity: update on Toll-like receptors", Nat Immunol, 11, pp.373~384 (2010)
84. Simmer F, "MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer", Oncotarget, 6, pp.22996~23007 (2015)
85. Mlcochova J, "MicroRNA expression profiling identifies miR-31-5p", 3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab, 2015, pp.6, 38695~38704
86. Perez-Carbonell L, "MiR-320e is a novel prognostic biomarker in colorectal cancer", Br J Cancer, 113, pp.83~90 (2015)
87. Lee HC, "Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer", J Cancer Res Clin Oncol, 136, pp.1073~1078 (2010)
88. Li T, "miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer", Oncol Rep, 33, pp.607~614 (2015)
89. Boni V, "miR-192", miR-215influence 5-fluorouracil resistance through cell cyclemediated mechanisms complementary to its posttranscriptional thymidilate synthase regulation, 2010, pp.9, 2265~2275
90. Hansen TF, "Changes in circulating microRNA-126during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer", Br J Cancer, 112, pp.624~629 (2015)
91. Zhang Y, "Novel epigenetic CREB-miR-630 signaling axis regulates radiosensitivity in colorectal cancer", PLoS One, 10, pp.e0133870~ (2015)
92. Diaz R, "Deregulated expression of miR-106a predicts survival in human colon cancer patients", Genes Chromosomes Cancer, 47, pp.794~802 (2008)
93. Sakaguchi M, "miR-137 Regulates the tumorigenicity of colon cancer stem cells through the inhibition of DCLK1", Mol Cancer Res, 14, pp.354~362 (2016)
94. Wang CJ, "Clinicopathological significance of microRNA-31, -143 and -145expression in colorectal cancer", Dis Markers, 26, pp.27~34 (2009)
95. Wang B, "miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelialmesenchymal transition", Cell Death Dis, 5, pp.e1335~ (2014)
96. Li J, "miR-433 reduces cell viability and promotes cell apoptosis by regulating MACC1 in colorectal cancer", Oncol Lett, 13, pp.81~88 (2017)
97. Guo ST, "MicroRNA-497targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer", Oncogene, 32, pp.1910~1920 (2013)
98. He D, "Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer", Mol Cancer, 14, pp.73~ (2015)
99. Wang Q, "Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer", PLoS One, 7, pp.e44398~ (2012)

관련 논문AI추천